CIDARA THERAPEUTICS INC (CDTX) Stock Balance Sheet
NASDAQ:CDTX • US1717572069
Current stock price
221.38 USD
+0.06 (+0.03%)
At close:
221.38 USD
0 (0%)
After Hours:
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 293.65M | 189.82M | 35.78M | 32.73M | 59.68M | |||
| Marketable Securities | 126.37M | N/A | N/A | N/A | N/A | |||
| Receivables | 1.86M | 1.69M | 16.25M | 5.83M | 5.36M | |||
| Inventories | N/A | N/A | 6.10M | 0.00 | N/A | |||
| Other Current Assets | 20.94M | 19.22M | 2.73M | 6.53M | 6.66M | |||
| Total Current Assets | 442.82M | 210.74M | 60.85M | 45.09M | 71.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.09M | 3.96M | 5.13M | 1.32M | 2.54M | |||
| Investments And Advances | 50.16M | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 23.58M | 96.00K | 1.05M | 1.07M | 1.08M | |||
| Total Non-Current Assets | 75.83M | 4.06M | 6.17M | 2.39M | 3.63M | |||
| TOTAL ASSETS | 518.65M | 214.80M | 67.03M | 47.49M | 75.33M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 0.00 | 264.00K | 218.00K | 0.00 | 2.59M | |||
| Accrued Expenses | 91.49M | 45.68M | 38.33M | 25.34M | 16.20M | |||
| Accounts Payable | 4.35M | 3.61M | 3.77M | 1.45M | 1.30M | |||
| Other Current Liabilities | N/A | 0.00 | 25.09M | 14.61M | 13.92M | |||
| Total Current Liabilities | 95.84M | 49.55M | 67.42M | 41.40M | 34.02M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 310.00K | 575.00K | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 424.00K | 1.62M | 7.25M | 20.52M | 19.73M | |||
| Total Non-Current Liabilities | 424.00K | 1.93M | 7.82M | 20.52M | 19.73M | |||
| TOTAL LIABILITIES | 96.26M | 51.49M | 75.24M | 61.92M | 53.75M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -743.69M | -611.26M | -441.43M | -418.50M | -377.17M | |||
| Additional Paid In Capital | 1.17B | 774.57M | 433.21M | 404.06M | 398.73M | |||
| Common Shares | 3.00K | 1.00K | 9.00K | 7.00K | 7.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 29.34M | 10.95M | 4.53M | 3.62M | 3.39M | |||
| Tangible Book Value per Share | 14.40 | 14.92 | -1.81 | -3.98 | 6.36 | |||
| Total Shareholders' Equity | 422.39M | 163.31M | -8.21M | -14.44M | 21.57M | |||
| TOTAL LIABILITIES AND EQUITY | 518.65M | 214.80M | 67.03M | 47.49M | 75.33M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.00 | -0.07 | N/A | N/A | |||
| Current Ratio | 4.62 | 4.25 | 0.90 | 1.09 | 2.11 | |||
| Return On Assets (ROA) | -35.62% | -79.06% | -34.21% | -70.72% | -56.38% | |||
| Return On Equity (ROE) | -43.74% | -103.99% | N/A | N/A | -196.85% | |||
All data in USD , ROIC based on taxRate of 0.21